Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

9930039A11Rik Inhibitors

Ring finger protein 222," encoded by the gene "21618," is a member of the RING (Really Interesting New Gene) family of proteins, which are characterized by the presence of a RING finger domain. This domain typically consists of a C3HC4 amino acid motif that binds two zinc ions, and it is integral to the protein's role in mediating a variety of cellular processes.The gene "21618" serves as a unique identifier within a genomic database, pinpointing the specific genetic sequence that codes for the ring finger protein 222. This protein, through its RING finger domain, is often involved in ubiquitination, a post-translational modification process where ubiquitin molecules are attached to substrate proteins. Ubiquitination can signal for protein degradation via the proteasome, alter protein function, or affect protein localization within the cell.

As with other RING finger proteins, ring finger protein 222 may act as an E3 ubiquitin ligase, which plays a crucial role in the transfer of ubiquitin from the E2 conjugating enzyme to specific substrate proteins. The specificity of the ubiquitination process is largely determined by the E3 ligase, thus ring finger protein 222 may be involved in targeting specific proteins for ubiquitination, influencing various cellular pathways including cell cycle regulation, DNA repair, signal transduction, and transcriptional regulation.The detailed functions of ring finger protein 222 are likely to be context-dependent, varying with cell type, developmental stage, and external stimuli. Studying this protein's interactions and ubiquitination targets could provide valuable insights into the intricate regulatory networks within cells. Disruptions in the function of RING finger proteins like ring finger protein 222 are associated with a range of diseases, including cancer, neurodegenerative disorders, and immune system dysfunctions, due to their pivotal roles in controlling protein homeostasis and signaling pathways.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 is a proteasome inhibitor that could indirectly affect the ubiquitin-mediated processes involving RNF222.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib is another proteasome inhibitor, potentially impacting protein degradation pathways involving RNF222.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Lactacystin inhibits the proteasome, potentially affecting the function of ubiquitin ligases like RNF222.

ATM/ATR Kinase Inhibitor Inhibitor

905973-89-9sc-202964
5 mg
$104.00
8
(1)

MLN4924 inhibits NEDD8-activating enzyme, affecting ubiquitin-like protein conjugation pathways and possibly RNF222.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

PYR-41 is a ubiquitin-activating enzyme E1 inhibitor, potentially affecting RNF222's ubiquitin-related activity.

PR 619

2645-32-1sc-476324
sc-476324A
sc-476324B
1 mg
5 mg
25 mg
$75.00
$184.00
$423.00
1
(0)

PR-619 is a broad-spectrum deubiquitinase inhibitor, potentially impacting RNF222's related pathways.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Thalidomide has been shown to target the ubiquitin-proteasome system, potentially affecting RNF222.

Carfilzomib

868540-17-4sc-396755
5 mg
$40.00
(0)

Carfilzomib is a selective proteasome inhibitor, potentially influencing RNF222-related processes.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$134.00
$215.00
$440.00
$496.00
19
(2)

Epoxomicin is a proteasome inhibitor, potentially affecting ubiquitin-related functions of RNF222.

Spautin-1

1262888-28-7sc-507306
10 mg
$165.00
(0)

TAK-243 is a ubiquitin-activating enzyme E1 inhibitor, potentially influencing RNF222.